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Methods: Pre- and postprocedural MSCT was performed in 40 patients. TAVI size
selection was done on the basis of anulus cross sectional measurements by MSCT so that
the nominal TAVI device CSA always exceeded the anNulus CSA. In preprocedural data
sets we determined the valve calcium score, the CSA and the ovality index of the aortic
anulus. In postprocedural data sets maximum and minimum diameter and the degree of
circularity at three levels (ventricular end, anulus, aortic end) was determined.
Results: The average expansion ratio of the Edwards Sapien XT device was 95% and the
circularity Index was 97%. In multivariate regression analysis neither calcium score nor
ovality index of the native anulus were associated with under or non circular expansion
of the device. The only parameter predicting underexpansion was the degree of
oversizing. Underexpansion of the device was not associated with increased transaortic
pressure gradients or with the incidence of paravalvular aortic regurgitation. The degree
of oversizing was however positiveley associated with the incidence of new conduction
disturbances. In the entire cohort no aortic regurgitation  mild was observed.
Conclusions: MSCT guided TAVI device sizing is associated with almost complete and
symmetric expansion of the Edwards Sapien XT device and the absence of significant
aortic regurgitation. Calcification or ovality of the native anulus do not influence the
expansion pattern. To rigorous device oversizing however is associated with new
conduction disturbances and device underexpansion.
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Background: New left bundle branch block (LBBB) or need for permanent pacing due
to AV-block are frequent after transcatheter aortic valve implantation (TAVI). This study
evaluated the impact of new conduction defect after TAVI on the evolution of left
ventricular (LV) function during one year follow-up.
Methods: A total of 90 consecutive patients treated with TAVI and 12 months
echocardiographic follow-up were included in the study. In 39 patients a new conduction
defect (new LBBB or need for permanent pacemaker activity) persisted one month after
TAVI. In 51 patients no persistent new conduction defect was observed. 2D echocardi-
ography using parasternal short-axis, apical 4-chamber and 2-chamber views was
performed before TAVI and at 1 year follow-up to determine left ventricular volumes and
ejection fraction based on Simpson’s rule. Speckle-tracking echocardiography was
applied using standard LV short-axis images to assess the effect of new conduction defect
on time-to-peak radial strain of different LV segments as parameter of LV dyssynchrony.
Results: New conduction defect resulted in marked heterogeneity in time-to-peak strain
between the 6 analysed short-axis segments. During one year follow-up after TAVI there
was a significant increase in LVEF in patients without new LBBB (5311% pre to
5910% at follow-up; p0.001), while there was no change in LVEF in patients with
new conduction defect (5211% pre to 5112% at follow-up, p0.740). Change in LV
endsystolic volume was also significantly different between patient groups (1.014.2
vs. 11.215.7 ml, p0.042). New conduction defect was an independent predictor of
reduced LVEF at 12 months follow-up after TAVI.
Conclusions: LVEF improves after TAVI for treatment of severe aortic stenosis in
patients without new conduction defect. In patients with a new conduction defect after
TAVI, there is no improvement in LVEF at follow-up.
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Background: Transthoracic echocardiography (TTE) is the reference technique for
evaluating aortic stenosis (AS), but in certain cases, estimation of the average gradient and
aortic valve area can be difficult. We aimed to assess the feasibility and utility of
measuring simultaneous transaortic pressure using a fractional flow reserve (FFR)
guidewire in doubtful aortic stenosis.
Methods: Between January 2009 and December 2011, 57 patients with symptoms
possibly related to severe AS that was poorly evaluated by echocardiography underwent
right and left heart catheterization for assessment of aortic valve area with the Gorlin &
Gorlin formula. Transaortic pressure was obtained by 2 invasive methods, namely
conventional pullback method from the left ventricle (LV) towards the aorta (PM) with
subsequent computerized superposition of the pressure curves, and (2) simultaneous
method using a FFR wire introduced into the LV (SM).
Results: Reasons for inaccurate assessment by echocardiography were atrial fibrillation
(75%) and/or low LV ejection fraction (38%). Results of evaluation of mean aortic valve
gradient and aortic valve area are summarized in the table below. Agreement between
methods (using the kappa coefficient) for severe aortic stenosis defined by an aortic-valve
area 0.6 cm2/m2 was 0.36 between SM and PM, 0.07 between SM and TTE, and0.12
between PM and TTE. These findings led to a decision to change therapeutic strategy in
8 patients (14%).
Conclusions: Simultaneous measurement of trans-aortic pressure using a FFR guidewire
is feasible and may be an attractive and accurate method for evaluation of doubtful aortic
stenosis.
Simultaneous
pressure
Pullback
method
Echocardiographic
measurements
Mean aortic valve
gradient, mmHg
30.514.4 23.69.9 28.88.0
p vs Pullback 0.0001 — 0.0002
p vs echo 0.241 — —
Aortic valve area,
cm2/m2
0.460.2 0.480.15 0.490.1
p vs Pullback 0.003 — 0.529
p vs echo 0.074 — —
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Background: Patients with severe aortic stenosis, but who are not good candidates for
surgical aortic valve replacement can be treated with trans-catheter aortic valve implan-
tation (TAVI). This latest technology however comes at a considerable cost. The objective
of the current study is to calculate and analyse these costs.
Methods: Data were retrospectively collected from all patients who underwent a
transaortic valve insertion in the University Hospital Antwerp from December 2007 until
June 2011. Costs of hospitalisation were retrieved on the basis of invoices and patients
characteristics from medical records. Costs were actualized to 2011 using 2011 tariffs and
determinants analysed (Wilcoxon rank sum test and Spearman rho’s correlation).
Results: 89 patients were included. Analyses are performed on 86 patients with complete
cost data. All interventions were done by a single physician using Core Valve ®. Mean
age of the patients was 82 years; 73% of patients are in NYHA 3 and 4. Mean costs
amount to €38,521 (sd €8,587) with median costs only slightly smaller (€37,079). The
costs of the valve (€17,090 per valve) and daily nursing and hotel costs (€ 594 per day)
are most important, amounting to respectively 46% and 26% of total costs. There is weak
evidence of a learning effect: costs decrease somewhat over the years (p0.091).
Pulmonary hypertension (p0.04) and hyperlipidemia (0.0049) have a siginificant
association with costs as well. The distribution of costs is not significantly different for
other background characteristics of the patient. (see table 1)
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